MainboardGMP
LIVE
LIVE GMP
Shellz India Ltd₹+13·Tonbo Imaging India Ltd₹+495·Zetwerk Manufacturing Business Ltd₹+11·Bonfiglioli Transmissions Ltd₹+138·Sahajanand Medical Technologies Ltd₹+42·Ravita Engineering Services Ltd₹+3·Fusion CX Ltd₹+20·Jio Platforms Ltd₹+222·Paras Healthcare Ltd₹+90·HD Fire Protect Ltd₹+80·Vaibhav Vyapaar Ltd₹0·R.K.Fashion Accessories Ltd₹0·Vishal Nirmiti Ltd₹+8·Nityas Gems & Jewellery Ltd₹+1·Paramount Syntex Ltd₹0·Acme India Industries Ltd₹+47·TNA Solutions Ltd₹+10·Dove Soft Ltd₹0·Omara Ventures India Ltd₹0·Shellz India Ltd₹+13·Tonbo Imaging India Ltd₹+495·Zetwerk Manufacturing Business Ltd₹+11·Bonfiglioli Transmissions Ltd₹+138·Sahajanand Medical Technologies Ltd₹+42·Ravita Engineering Services Ltd₹+3·Fusion CX Ltd₹+20·Jio Platforms Ltd₹+222·Paras Healthcare Ltd₹+90·HD Fire Protect Ltd₹+80·Vaibhav Vyapaar Ltd₹0·R.K.Fashion Accessories Ltd₹0·Vishal Nirmiti Ltd₹+8·Nityas Gems & Jewellery Ltd₹+1·Paramount Syntex Ltd₹0·Acme India Industries Ltd₹+47·TNA Solutions Ltd₹+10·Dove Soft Ltd₹0·Omara Ventures India Ltd₹0·
Home › IPOs › Moneyview Ltd › Subscription
MO
Moneyview Ltd
CLOSED NSE & BSE Bookbuilding IPO Fresh capital cum OFS Moneyview IPO GMP
GREY MARKET PREMIUM
₹ + 13
+38% expected return
EST. LISTING PRICE
₹47
Issue Price: ₹ 34
Back to IPOs Check Allotment Website
Issue Price
₹34
Face Value
₹1
Lot Size
441 shares
IPO Size
Agg. upto ₹1,092 Cr
Open Date
24 Sep 2026
Close Date
28 Sep 2026
Allotment
29 Sep 2026
Listing Date
01 Oct 2026
Exchange
NSE & BSE

Moneyview IPO Details: Price, Dates & Financials

The Moneyview IPO GMP strength score is 7.2 out of 10, which the dashboard rates as Good. The Moneyview IPO valuation is tagged Strong. The Moneyview IPO is subscribed 71.40 times overall so far. Amounts are calculated at the upper price band of ₹34.

IPO Analytics Dashboard
LIVE
Moneyview IPO GMP Insights
📊
Valuation
Strong
Moneyview IPO GMP Strength Score
7 / 10 Good
0–3 Weak 3–6 Moderate 6–8 Good 8–10 Strong
Moneyview IPO Category-wise Subscription Shares offered, bid & amount
Category Sub (x) Offered Bid For
🏦 QIB 92.71 160,541,216 14,884,062,669
💼 NII / HNI 119.98 48,162,366 5,778,533,250
👤 Retail (RII) 20.13 112,378,853 2,262,290,310
Σ Total 71.40 321,082,435 22,924,886,229

* Amount calculated at upper price band (₹34) ·  ** Total includes all investor categories

Moneyview IPO Application Sizing Minimum investment by category
👤 Retail Investors ?
Min. Lots 1
Shares / Lot 441
Min. Investment ₹14,994
💼 HNI Investors ?
Min. Lots 67
Min. Shares 29,547
Min. Investment ₹1,004,598
Moneyview IPO Valuation — EPS & P/E Pre & post-issue metrics
Pre-Issue EPS ?
₹ 2
Post-Issue EPS ?
₹ 4
Pre-Issue P/E ?
22 x
Post-Issue P/E ?
9 x
Moneyview IPO Timeline & Key Dates
  1. 1 💳 Initiation of Refund 30 Sep 2026
  2. 2 📂 Credit of Shares to Demat 30 Sep 2026
  3. 3 🔒 Lock-in Period (30%) Thu, Oct 29, 2026
  4. 4 🔒 Lock-in Period (50%) Mon, Dec 28, 2026
Investor Interpretation
  • The IPO P/E of 9x reflects a strong valuation relative to typical market ranges.
  • Pre-issue EPS of ₹2 compares to post-issue EPS of ₹4 after dilution.

This IPO shows moderate investor interest. Review financial details and compare valuation with industry peers before investing.

✅ Check Allotment Status
Moneyview IPO Subscription FAQs
Moneyview IPO is subscribed 71.40x overall (Retail 20.13x, QIB 92.71x, NII/HNI 119.98x).
The retail (RII) portion of Moneyview IPO is subscribed 20.13x.
Moneyview IPO — QIB 92.71x, NII/HNI 119.98x.
In Moneyview IPO, retail investors can apply for a minimum of 1 lot(s) (₹₹14,994); HNI/sNII minimum 67 lots (₹₹1,004,598).
Shares offered by category — QIB 160,541,216 shares, Retail 112,378,853 shares.
Moneyview IPO valuation — pre-issue EPS ₹1.58, post-issue EPS ₹3.95, pre-issue P/E 21.52, post-issue P/E 8.61.
30% lock-in period ends: Thu, Oct 29, 2026. 50% lock-in period ends: Mon, Dec 28, 2026.
Subscription is shares bid for divided by shares offered in that category. If 10 lakh shares are offered and 50 lakh are bid for, the category is subscribed 5 times. Final numbers are confirmed after the bidding closes.

GMP and IPO data are unofficial and for information only — not investment advice. Read the full disclaimer.